About the authors

Fabrizio Schifano, MD, MRCPsych, Dip Psychiatry, Dip Clin Pharmacology

Professor Fabrizio SchifanoChair in Clinical Pharmacology and Therapeutics, University of Hertfordshire School of Pharmacy (Hatfield, UK); Consultant Psychiatrist, Addictions Directorate, Hertfordshire Partnership NHS Foundation Trust (UK).

 

Professor Schifano is one of the very few physicians with training and specialist qualifications in both psychiatry and clinical pharmacology. He has made contributions to several areas of addiction psychiatry and general psychiatry, including stimulant drugs, mortality studies and drugs and the internet.

 

He was recently awarded the ACCEA Bronze Award (9 national points).
He is a member of the Advisory Council on the Misuse of Drugs (ACMD)
and the Specialist (Psychiatry) Advisory Group for the European Medicines Agency (EMA).

 

Email: f.schifano@herts.ac.uk

 

Declaration of interests: None


 

Antonio Albanese, MD, Specialist Associate of the Royal College of Psychiatrists

Dr Antonio Albanese

Specialty Doctor, Adult Mental Health Services, East London NHS Foundation Trust (UK).

 

Dr Albanese holds a Doctorate in Medicine and Surgery and a Postdoctorate Specialist Diploma in Psychiatry and Psychotherapy from the University of Padova (I). He is currently working in the Tower Hamlets Community Rehabilitation and Recovery Team and has had two years' work experience with different drug and alcohol teams in the UK. 

 

His research interests range from the psychopathological and epistemological issues of mental disorders to the psychopharmacological and clinical aspects of substance misuse. He is an active collaborator in both the Psychonaut Web Mapping and the ReDNet Research groups, and has also published work on empathy and autism.

 

Email: antonio.albanese@eastlondon.nhs.uk

 

Declaration of interests: None

 

© 2012 Royal College of Psychiatrists